Marinus Pharmaceuticals Inc (MRNS)
1.40
0.00 (0.00%)
USD |
NASDAQ |
Apr 29, 16:00
1.40
0.00 (0.00%)
After-Hours: 20:00
Marinus Pharmaceuticals Total Assets (Quarterly): 170.91M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 170.91M |
| September 30, 2023 | 200.81M |
| June 30, 2023 | 201.20M |
| March 31, 2023 | 226.82M |
| December 31, 2022 | 259.52M |
| September 30, 2022 | 184.84M |
| June 30, 2022 | 109.38M |
| March 31, 2022 | 140.81M |
| December 31, 2021 | 136.84M |
| September 30, 2021 | 158.87M |
| June 30, 2021 | 124.99M |
| March 31, 2021 | 133.86M |
| December 31, 2020 | 150.46M |
| September 30, 2020 | 99.53M |
| June 30, 2020 | 113.44M |
| March 31, 2020 | 84.56M |
| December 31, 2019 | 98.84M |
| September 30, 2019 | 45.80M |
| June 30, 2019 | 58.96M |
| March 31, 2019 | 67.62M |
| December 31, 2018 | 75.23M |
| Date | Value |
|---|---|
| September 30, 2018 | 42.10M |
| June 30, 2018 | 48.69M |
| March 31, 2018 | 55.03M |
| December 31, 2017 | 60.67M |
| September 30, 2017 | 64.66M |
| June 30, 2017 | 22.10M |
| March 31, 2017 | 26.82M |
| December 31, 2016 | 31.45M |
| September 30, 2016 | 38.64M |
| June 30, 2016 | 46.16M |
| March 31, 2016 | 52.79M |
| December 31, 2015 | 59.65M |
| September 30, 2015 | 36.75M |
| June 30, 2015 | 41.04M |
| March 31, 2015 | 46.35M |
| December 31, 2014 | 50.21M |
| September 30, 2014 | 47.56M |
| June 30, 2014 | 9.479M |
| March 31, 2014 | 10.56M |
| December 31, 2013 | 11.82M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
45.80M
Minimum
Sep 2019
259.52M
Maximum
Dec 2022
142.13M
Average
136.84M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 787.22M |
| Soligenix Inc | 9.797M |
| Actinium Pharmaceuticals Inc | 81.44M |
| Macrogenics Inc | 298.42M |
| ADMA Biologics Inc | 329.18M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 154.14M |
| Shareholders Equity (Quarterly) | 16.76M |
| Debt to Equity Ratio | 4.353 |
| Current Ratio | 4.068 |
| Net Debt Paydown Yield | -0.07% |